What is SLIT?
A Natural Path to Allergy Freedom.
Sublingual Immunotherapy (SLIT) is a natural, effective, and safe treatment that helps the body build tolerance to allergens — the substances that trigger allergic reactions such as dust mites, pollen, mold, pet dander, and more.
By introducing small, purified doses of the allergen under the tongue, the immune system gradually learns to tolerate these triggers. Over time, this reduces or even eliminates allergy symptoms. SLIT is made from natural protein extracts and does not contain antibiotics, steroids, or antihistamines, making it safe for both adults and children.
Why Choose Immunotherapy?
The Only Treatment That Fixes the Root Cause
Immunotherapy is the only medical treatment proven to modify the natural course of allergic diseases. Unlike regular medicines that only relieve symptoms, immunotherapy works on the root cause — helping prevent the progression of allergies and asthma.
Clinical research (EAACI, European Declaration on Immunotherapy, 2011) confirms that allergen immunotherapy offers long-lasting relief even after treatment ends. Many patients continue to experience improvement for up to 12 years after completing therapy.
How SLIT Works?
A Simple 3-Step Process:
Diagnosis
Customized Treatment
Tolerance Development
This approach has been shown to reduce the need for antihistamines and steroid medications by 60–74%, making it an excellent long-term alternative to daily allergy pills or sprays.
Proven Benefits of Sublingual Immunotherapy
Why Patients Love SLIT
Long-Term Relief
Helps reduce symptoms of allergic rhinitis, asthma & eye allergies over time.
Home-Based Treatment
Safe and easy to take under the tongue—no injections needed.
Less Medication Needed
SLIT reduces dependence on antihistamines and steroid sprays.
Prevents New Allergies
May help stop the progression to new allergies or asthma.
Suitable for All Ages
Safe for adults, seniors & children as young as age 5.
Clinically Proven
Strong evidence for dust mites, pollen & other common allergens.
When SLIT Is Recommended
Who Should Consider SLIT?
SLIT is suitable for patients diagnosed with IgE-mediated allergies:
-
Moderate to severe allergic rhinitis
-
Rhinoconjunctivitis
-
Controlled mild–moderate asthma
-
Some food allergies (being researched)
SLIT is suitable for all age groups — from young children to older adults.
When SLIT Is Not Recommended
Situations Where SLIT May Not Be Suitable
SLIT is generally very safe, but there are a few cases where it may not be recommended:
- Active oral ulcers or eosinophilic esophagitis
- Uncontrolled asthma or active infections with fever
- Pregnancy: Treatment can be continued if already started, but not initiated during pregnancy
- Beta-blocker use: These medications may interfere with emergency treatment for allergic reactions
- Autoimmune or immunodeficiency conditions: SLIT may be used cautiously under medical supervision
According to global allergy authorities like AAAAI and EAACI, it is safe to continue immunotherapy during pregnancy with stable doses.
Global Clinical Support
Clinically Proven. Internationally Trusted.
Multiple international studies have proven the effectiveness of SLIT in both children and adults.
- Strong results for grass pollen-induced rhinoconjunctivitis and asthma
- Similar clinical benefits to traditional allergy injection therapy
- Supported by European Academy of Allergy and Clinical Immunology (EAACI) and American Academy of Allergy, Asthma & Immunology (AAAAI)
Despite its proven success, awareness about Allergen Immunotherapy (AIT) remains low. Doctors, pharmacists, and patient organizations continue to play a vital role in educating patients about this transformative allergy treatment.
Take Control of Your Allergies — Naturally
With Sublingual Immunotherapy, you don’t just mask allergy symptoms — you train your immune system to overcome them. Safe, effective, and scientifically proven, SLIT offers a path to long-term allergy freedom and better quality of life.
Experience real, lasting relief — with immunotherapy that works from within.



